Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:7092583.
doi: 10.1155/2016/7092583. Epub 2016 Jul 20.

Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso

Affiliations

Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso

Ina Marie Angèle Traore et al. Biomed Res Int. 2016.

Abstract

High-risk human papillomavirus (HPV) is found in over 99% of cervical cancers. The aim of this study was to determine the prevalence of HPV in a population of women in Bobo-Dioulasso and to identify the high-risk types present in these women. From May to June, 2015, 181 women who came for consultation at the Souro Sanou University Hospital of Bobo-Dioulasso have been included in this study. Uterine endocervical swabs have been taken in these women. DNA obtained by extraction from the samples thus collected was used to determine the prevalence of high-risk human papillomavirus genotypes through real-time PCR. The age of the women ranged from 20 to 56 years with a mean of 35.3 ± 8.1 years. The prevalence of infection by high-risk HPV types was 25.4% (46/181). The most common high-risk HPV genotypes were HPV 39 (18.5%), HPV 52 (16.7%), HPV 18 (14.8%), and HPV 35 (13.0%). HPV 16 which is included in the HPV vaccines was not found in the population studied. This type of study which is the first one in Bobo-Dioulasso has showed a high prevalence of genotypes HPV 39, HPV 52, and HPV 35 which are not yet covered by a vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of high-risk HPV genotypes found among the women in the study.

Similar articles

Cited by

References

    1. Bruni L., Diaz M., Castellsagué X., Ferrer E., Bosch F. X., de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of Infectious Diseases. 2010;202(12):1789–1799. doi: 10.1086/657321. - DOI - PubMed
    1. Dunne E. F., Unger E. R., Sternberg M., et al. Prevalence of HPV infection among females in the United States. The Journal of the American Medical Association. 2007;297(8):813–819. doi: 10.1001/jama.297.8.813. - DOI - PubMed
    1. Franco E. L., Villa L. L., Sobrinho J. P., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. The Journal of Infectious Diseases. 1999;180(5):1415–1423. doi: 10.1086/315086. - DOI - PubMed
    1. Muñoz N., Castellsagué X., de González A. B., Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(supplement 3):S1–S10. doi: 10.1016/j.vaccine.2006.05.115. - DOI - PubMed
    1. Walboomers J. M., Jacobs M. V., Manos M. M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology. 1999;189(1):12–19. doi: 10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f. - DOI - PubMed

LinkOut - more resources